azacitidine · Injection, Powder, Lyophilized, For Solution

What changed in the last 90 days

Every detected change for azacitidine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Nucleoside Metabolic Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• pentostatin· in shortage
• (daunorubicin and cytarabine) liposome· 1 maker
• azacitidine for· 1 maker
• fluorouracil cream, 0.5%· 1 maker
• gemcitabine intravesical· 1 maker
• purixan· 1 maker
• trifluridine and tipiracil· 1 maker
• cedazuridine and decitabine· 3 makers
• trifluridine· 6 makers
• mercaptopurine· 7 makers
• cytarabine· 9 makers
• fludarabine phosphate· 10 makers

Common questions

Is Azacitidine in shortage right now?

Yes. FDA currently lists Azacitidine in shortage, with the reason given as "other". This page is rebuilt every morning from FDA's shortage database.

Who makes Azacitidine?

36 companies have marketed Azacitidine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

• In shortage now — Azacitidine, Injection, 100 mg (NDC 68001-313-56)Dec 22, 2020
• In shortage now — Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01)Dec 22, 2020
• In shortage now — Azacitidine, Injection, 100 mg (NDC 16729-306-10)Dec 21, 2020
• In shortage now — Azacitidine, Injection, 100 mg (NDC 43598-305-62)Dec 18, 2020
• In shortage now — Azacitidine, Injection, 100 mg (NDC 72485-201-01)Dec 18, 2020
• In shortage now — Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01)Dec 18, 2020